- ►chestpubs.org DE Singer, AS Go - Clinics in geriatric medicine, 2001 - Elsevier Based solely on observational data, long-term anticoagulation has been a favored
therapy to prevent stroke in rheumatic AF. 47 It was unclear whether
anticoagulants would work in nonrheumatic AF or whether they would be ... Cited by 550 - Related articles - BL Direct - All 17 versions
- ►ahajournals.org J Broderick, S Connolly, E Feldmann, D … - Circulation, 2007 - Am Heart Assoc Methods— A formal literature search of Medline was performed through the end
date of August 2006. The results of this search were complemented by additional
articles on related issues known to the writing committee. Data were ... Cited by 215 - Related articles - All 14 versions
- ►annals.org [PDF] RG Hart, LA Pearce, MI Aguilar - Annals of Internal Medicine, 2007 - Am Coll Physicians Purpose: To characterize the efficacy and safety of antithrombotic agents for
stroke prevention in patients who have atrial fibrillation, adding 13 recent
randomized trials to a previous meta-analysis. Cited by 194 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org EM Hylek, C Evans-Molina, C Shea, LE … - Circulation, 2007 - Am Heart Assoc Methods and Results— Consecutive patients who started warfarin were identified
from January 2001 to June 2003 and followed for 1 year. Patients had to be 65
years of age, have established care at the study institution, and have ... Cited by 163 - Related articles - All 6 versions
- ►ua.edu [PDF] J Mant, FDR Hobbs, K Fletcher, A Roalfe, D … - The Lancet, 2007 - Elsevier 973 patients aged 75 years or over (mean age 81·5 years, SD 4·2) with atrial
fibrillation were recruited from primary care and randomly assigned to warfarin
(target international normalised ratio 2–3) or aspirin (75 mg per day). ... Cited by 127 - Related articles - All 30 versions
HC Koennecke - Neurology, 2006 - AAN Enterprises Results: Prevalence data from more than 5,200 subjects were analyzed. In elderly
subjects without cerebrovascular disease, CMB prevalence is between 5% and 6%,
associated with advanced age, while data are inconsistent with regard to ... Cited by 113 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org RG Hart, SB Tonarelli, LA Pearce - Stroke, 2005 - Am Heart Assoc Summary of Review— ICH rates range from 0.3% to 0.6% per year during oral
anticoagulation in recent reports. Major risk factors are advanced patient age,
elevated blood pressure, intensity of anticoagulation, and previous ... Cited by 108 - Related articles - All 9 versions
- ►ahajournals.org MC Fang, DE Singer, Y Chang, EM Hylek, LE … - Circulation, 2005 - Am Heart Assoc Methods and Results— We prospectively studied 13 559 adults with AF and
recorded data on patients' clinical characteristics and the occurrence of
incident hospitalizations for ischemic stroke, peripheral embolism, and ... Cited by 95 - Related articles - All 8 versions
GYH Lip, SJ Edwards - Thrombosis research, 2006 - Elsevier We identified 13 trials (n = 14,423 participants) of sufficient quality to be
included in the analysis. Adjusted-dose warfarin significantly reduced the risk
of ischaemic stroke or systemic embolism compared with aspirin (relative ... Cited by 85 - Related articles - All 9 versions
Y Caraco, S Blotnick, M Muszkat - Clinical Pharmacology & Therapeutics, 2007 - nature.com Warfarin anticoagulation effect is characterized by marked variability, some of
which has been attributed to CYP2C9 polymorphisms. This study prospectively
examines whether a priori knowledge of CYP2C9 genotype may improve warfarin ... Cited by 83 - Related articles - All 4 versions
